CASTLE BIOSCIENCES INC's ticker is CSTL and the CUSIP is 14843C105. A total of 150 filers reported holding CASTLE BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $488,121 | -37.9% | 28,900 | -49.5% | 0.00% | – |
| Q2 2023 | $785,484 | +22.1% | 57,251 | +102.2% | 0.00% | – |
| Q1 2023 | $643,362 | +73.0% | 28,317 | +79.2% | 0.00% | – |
| Q4 2022 | $371,932 | -62.8% | 15,800 | -58.7% | 0.00% | – |
| Q3 2022 | $999,000 | +166.4% | 38,300 | +124.0% | 0.00% | – |
| Q2 2022 | $375,000 | +13.0% | 17,100 | +131.1% | 0.00% | – |
| Q1 2022 | $332,000 | -83.2% | 7,400 | -83.9% | 0.00% | – |
| Q4 2021 | $1,972,000 | +16.3% | 46,014 | +80.4% | 0.00% | – |
| Q3 2021 | $1,696,000 | -51.2% | 25,500 | -46.2% | 0.00% | – |
| Q2 2021 | $3,474,000 | -24.5% | 47,377 | -29.6% | 0.00% | – |
| Q1 2021 | $4,604,000 | -18.9% | 67,267 | -20.5% | 0.00% | – |
| Q4 2020 | $5,680,000 | +1334.3% | 84,568 | +998.3% | 0.00% | – |
| Q3 2020 | $396,000 | -44.1% | 7,700 | -59.0% | 0.00% | – |
| Q2 2020 | $708,000 | – | 18,773 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXT CENTURY GROWTH INVESTORS LLC | 538,673 | $24,164,000 | 2.41% |
| Pembroke Management, LTD | 463,909 | $20,811,000 | 1.74% |
| Redwood Investments, LLC | 375,892 | $16,863,000 | 1.60% |
| Monarch Partners Asset Management LLC | 156,502 | $7,021,000 | 1.57% |
| PERKINS CAPITAL MANAGEMENT INC | 33,170 | $1,488,000 | 1.22% |
| Mesirow Financial Investment Management, Inc. | 7,985 | $358,000 | 1.21% |
| Grandeur Peak Global Advisors, LLC | 544,723 | $24,436,000 | 1.16% |
| Granahan Investment Management | 793,715 | $35,606,000 | 0.88% |
| WASATCH ADVISORS LP | 3,443,847 | $154,491,000 | 0.76% |
| Intrinsic Edge Capital Management LLC | 212,400 | $9,528,000 | 0.73% |